iTunes

Iniciando iTunes Store.Si iTunes no se inicia, haz clic en el icono de la aplicación iTunes en el Dock de Mac o en el escritorio de Windows.Progress Indicator
Abriendo el iBooks Store.Si iBooks no se abre, haz clic en la app iBooks del Dock.Progress Indicator
iTunes

iTunes is the world's easiest way to organize and add to your digital media collection.

No encontramos iTunes en este ordenador. Para comprar y descargar CTCAE-4 de Stefano Peruzzi, obtén iTunes ya.

¿Ya tienes iTunes? Haz clic en Ya tengo iTunes, para que sea activado.

I Have iTunes Descarga gratis
iTunes para Mac y PC

CTCAE-4

Por Stefano Peruzzi

Abre iTunes para comprar y descargar Apps.

Descripción

CTCAE-4 is a browsable reference to the CTCAE list of adverse event (AE) terms commonly encountered in oncology.

Each AE term is defined and accompanied by a grading scale that indicates the severity of the adverse event.

All AE terms are organized by the System Organ Classes (SOCs) defined by the Medical Dictionary for Regulatory Activities (MedDRA).

The CTCAE has been developed from the earlier vocabulary known as CTC (Common Toxicity Criteria).

Adverse events are common phenomena affecting patients being treated for cancer. With the availability of new agents and the multimodality interventions, it is critical to monitor systematically the AEs that are linked to oncology research.

CTCAE is fundamentally intended to be an agreed upon terminology for the designation, reporting and grading of AEs that occur in oncology research.

-------------------------
CTCAE serves several purposes
-------------------------
- To standardize AE reporting within the NCI oncology research community, across groups and modalities.
- To facilitate the evaluation of new cancer therapies, treatment modalities, and supportive measures.
- To aid in AE recognition and severity grading.
- To monitor safety data and for regulatory reporting.
- To define oncology research protocol parameters (e.g., eligibility criteria; dose limiting toxicity; maximum tolerated dose; dose modification).

CTC-AE 4 is based on original concept of
Martin E. Donach, M.D., NYU, USA

-------------------------
REFERENCES
-------------------------
National Cancer Institute
Common Terminology Criteria
for Adverse Events v4.0
NCI, NIH, DHHS. May 29, 2009
NIH publication # 09-7473

-------------------------
Karnofsky & ECOG scores
-------------------------
Am J Clin. Oncol.: Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982.The Eastern Cooperative Oncology Group, Robert Comis M.D., Group Chair.

Novedades de la versión 2.0

- rewritten from the scratch
- new UX for compatibility with all devices
- full searchable CTC-AE records
- new Karnofsky score
- new ECOG score
- portrait and landscape mode

Capturas de pantalla

Captura de pantalla del iPhone 1
Captura de pantalla del iPhone 2
Captura de pantalla del iPhone 3
Captura de pantalla del iPhone 4
Captura de pantalla del iPhone 5
Captura de pantalla del iPad 1
Captura de pantalla del iPad 2
Captura de pantalla del iPad 3
Captura de pantalla del iPad 4
Captura de pantalla del iPad 5
CTCAE-4
Ver en iTunes
Esta App esta diseñada para el iPhone y el iPad
  • USD 1.99
  • Categoría: Medicina
  • Actualizado :
  • Versión: 2.0
  • Tamaño: 1.0 MB
  • Idioma: Inglés
  • Vendedor:
Para descargar esta aplicación debes ser mayor de 17 años de edad
  • Información médica y de tratamiento frecuente/intensa

Compatibilidad: Requiere iOS 7.0 o posterior. Compatible con iPhone, iPad y iPod touch. Esta app está optimizada para iPhone 5.

Valoraciones de clientes

No hemos recibido suficientes valoraciones para poder mostrar un promedio de la versión actual de este artículo.